Axsome Therapeutics Inc

NASDAQ:AXSM   3:59:52 PM EDT
43.15
-1.10 (-2.49%)
4:11:07 PM EDT: $43.40 +0.25 (+0.58%)
Products

Axsome Therapeutics Inc - On June 24, Received From U.S. FDA Proposed Labeling For Co's Axs-05 Product Candidate

Published: 06/27/2022 11:41 GMT
Axsome Therapeutics Inc (AXSM) - Axsome Therapeutics Inc - on June 24, Received From U.S. FDA Proposed Labeling for Co's Axs-05 Product Candidate.
Axsome Therapeutics Inc - Proposed Labeling From FDA With Respect to NDA for Axs-05 for Treatment of Major Depressive Disorder.
Axsome Therapeutics Inc - Company is Reviewing Proposed Labeling and Will Reply to FDA to Secure Final Labeling Agreement.